“Anticancer Effects of Combined γ-Tocotrienol and PPARγ-Antagonist Treatment are Associated with a Suppression in Adipogenic Factor Expression” (2014) Journal of Pharmacy and Nutrition Sciences, 4(1), pp. 43–56. doi:10.6000/1927-5951.2014.04.01.7.